With regard to prostate cancer (PCa), MMP-2 rs243865 was significantly related to PCa incidence among the overall populations in the dominant model (OR = 1.365, 95% CI = 1.094–1.703, p = 0.006). Here, MMP2 is linked to prostate carcinoma.